Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-ared-4_04-cv-01169/USCOURTS-ared-4_04-cv-01169-29/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Product Liability

---

1

IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF ARKANSAS

WESTERN DIVISION

In re: 

PREMPRO PRODUCTS LIABILITY 

LITIGATION

DONNA SCROGGIN

v.

WYETH, et. al.

:

:

:

:

:

:

:

:

:

:

: 

MDL Docket No. 4:03CV1507-WRW

 4:04CV01169

 PLAINTIFF

 

 DEFENDANTS

ORDER

Clarification of the Court’s previous ruling on advertisement/marketing. It seems to me

that Plaintiff may now present marketing exhibits and advertisements (and documents related to

these) despite not having seen the advertisements. However, the substance of the exhibits must

relate to Plaintiff’s claims and the reason she took HRT, which from what I recall, was for

menopausal symptoms only (in other words, not osteoporosis, cardiac benefit, etc).

Upjohn’s Motion In Limine to Exclude Evidence From the Punitive Damages Phase &

Objections to Plaintiff’s Punitive Damage Exhibits (Doc. No. 563) and Wyeth’s Exclude

Plaintiff’s Proposed Exhibits Re Punitive Damages (Doc. No. 565) are GRANTED in PART and

DENIED in PART.

I. UPJOHN’S OBJECTIONS TO PUNITIVE EXHIBITS

Below are the rulings on Upjohn’s objections to Plaintiff’s proposed exhibits to be used

during the punitive damages phase of trial:

PX 3401 -- objection OVERRULED.

Case 4:04-cv-01169-BRW Document 601 Filed 03/03/08 Page 1 of 4
2

PX 5785 -- objection OVERRULED.

PX 10155 -- objection OVERRULED.

PX 10176 -- objection SUSTAINED -- exhibits is about osteoporosis.

PX 10177 -- objection SUSTAINED -- exhibits is about osteoporosis.

PX 10179 -- objection OVERRULED -- it appears that this document shows Upjohn’s

interpretation that Provera is used to treat abnormal bleeding.

PX 10180 -- objection OVERRULED.

PX 10189 -- objection OVERRULED.

PX 10425 -- objection SUSTAINED, because it involves events after Plaintiff stopped

using HRT. However, if Defendant opens the door by referring to its

conduct after Plaintiff stopped taking HRT, the exhibit may become

admissible. I will decide when or if the door has been opened.

PX 10719 -- objection OVERRULED. However, Plaintiff must establish foundation

for witness’s testimony during trial.

PX 11011 -- objection OVERRULED. However, Plaintiff must establish foundation

for witness’s testimony during trial.

PX 11012 -- objection OVERRULED. However, Plaintiff may refer only to the issues

in the document relevant to this case, e.g. “What We Do Not Know about

MPA in HRT Effects: Risk of breast cancer.” Redaction may be

necessary.

II. WYETH’S OBJECTIONS TO PUNITIVE EXHIBITS

Below are the rulings on Wyeth’s objections to Plaintiff’s proposed exhibits to be used

during the punitive damages phase of trial:

PX 15 -- objection SUSTAINED.

PX 22 -- objection OVERRULED.

PX 24 -- objection OVERRULED.

PX 145 -- objection SUSTAINED.

Case 4:04-cv-01169-BRW Document 601 Filed 03/03/08 Page 2 of 4
3

PX 153 -- objection SUSTAINED.

PX 154 -- objection OVERRULED.

PX 387 -- objection SUSTAINED, unless Plaintiff redacts to include only relevant

issues, e.g., breast cancer, menopausal symptoms, etc.

PX 427 -- objection OVERRULED.

PX 550 -- objection SUSTAINED.

PX 585 -- objection SUSTAINED.

PX 586 -- objection SUSTAINED, because it involves events after Plaintiff stopped

using HRT. However, if Defendant opens the door by referring to its

conduct after Plaintiff stopped taking HRT, the exhibit may become

admissible. I will decide when or if the door has been opened.

PX 708 -- objection SUSTAINED, because it involves events after Plaintiff stopped

using HRT. However, if Defendant opens the door by referring to its

conduct after Plaintiff stopped taking HRT, the exhibit may become

admissible. I will decide when or if the door has been opened.

PX 712 -- objection SUSTAINED, because it involves events after Plaintiff stopped

using HRT. However, if Defendant opens the door by referring to its

conduct after Plaintiff stopped taking HRT, the exhibit may become

admissible. I will decide when or if the door has been opened.

PX 713 -- objection SUSTAINED, because it involves events after Plaintiff stopped

using HRT. However, if Defendant opens the door by referring to its

conduct after Plaintiff stopped taking HRT, the exhibit may become

admissible. I will decide when or if the door has been opened.

PX 910 -- objection SUSTAINED, unless Plaintiff redacts to include only relevant

issues, e.g., breast cancer, menopausal symptoms, etc.

PX 1565 -- objection OVERRULED.

PX 4692 -- objection OVERRULED.

PX 5609 -- objection SUSTAINED.

PX 5655 -- objection SUSTAINED, because it involves events after Plaintiff stopped

using HRT. However, if Defendant opens the door by referring to its

conduct after Plaintiff stopped taking HRT, the exhibit may become

admissible. I will decide when or if the door has been opened.

Case 4:04-cv-01169-BRW Document 601 Filed 03/03/08 Page 3 of 4
4

PX 5677 -- objection OVERRULED.

PX 5733 -- objection SUSTAINED, unless Plaintiff redacts to include only relevant

issues, e.g., breast cancer, menopausal symptoms, etc.

PX 6558 -- objection OVERRULED.

PX 6776 -- objection OVERRULED.

PX 6891 -- objection SUSTAINED.

PX 7184 -- objection OVERRULED.

PX 7423 -- objection OVERRULED.

PX 8151 -- objection SUSTAINED, unless Plaintiff redacts to include only relevant

issues, e.g., breast cancer, menopausal symptoms, etc.

PX 10425 -- objection SUSTAINED, because it involves events after Plaintiff stopped

using HRT. However, if Defendant opens the door by referring to its

conduct after Plaintiff stopped taking HRT, the exhibit may become

admissible. I will decide when or if the door has been opened.

PX 8019A -- objection OVERRULED, but Plaintiff must redact to include only relevant

issues, e.g., breast cancer, menopausal symptoms, etc.

PX MA2568 -- objection OVERRULED.

CONTA025-026516-17 -- objection SUSTAINED, because it involves events after

Plaintiff stopped using HRT. However, if Defendant opens

the door by referring to its conduct after Plaintiff stopped

taking HRT, the exhibit may become admissible. I will

decide when or if the door has been opened.

CONTA025-026608-09 -- objection SUSTAINED, because it involves events after

Plaintiff stopped using HRT. However, if Defendant opens

the door by referring to its conduct after Plaintiff stopped

taking HRT, the exhibit may become admissible. I will

decide when or if the door has been opened.

IT IS SO ORDERED this 3rd day of March, 2008.

/s/ Wm. R. Wilson, Jr._________

UNITED STATES DISTRICT JUDGE

Case 4:04-cv-01169-BRW Document 601 Filed 03/03/08 Page 4 of 4